Expression of matrix metalloproteinase-26 in human normal placental cytotrophoblast cells as well as its regulation by activin A

Progress in Biochemistry and Biophysics

Volumn 32, Issue 1, 2005, Pages 25-30

  Qiu, Wei ^a   Zhao, Liang ^b   Bai, Su Xia ^a   Sang, Qing Xiang Amy ^c   Wang, Yan Ling ^a  

^a INSTITUTE OF ZOOLOGY   (China)

^b CHINA MEDICAL UNIVERSITY   (China)

^c FLORIDA STATE UNIVERSITY   (United States)

Author keywords

Activin A; Cytotrophoblast; Matrix metalloproteinase 26; Placenta

Indexed keywords

ACTIVIN A; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 26; MESSENGER RNA; UNCLASSIFIED DRUG;

ARTICLE; AUTOCRINE EFFECT; CELLULAR DISTRIBUTION; CYTOTROPHOBLAST; DOWN REGULATION; GESTATIONAL AGE; HUMAN; IMMUNOHISTOCHEMISTRY; NIDATION; PARACRINE SIGNALING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN STABILITY; PROTEIN SYNTHESIS REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

EID: 15944383031     PISSN: 10003282     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Nagase H and Woessner J F. Matrix Metalloproteinases. J Biol Chem, 1999, 274 (31): 21491-21494
2. Werb Z. ECM and cell surface proteolysis: Regulating cellular ecology. Cell, 1997, 91 (4): 439-442
3. Park H I, Ni J, Gerkema F E, et al. Identification and characterization of human endometase (matrix metalloproteinase-26) from endometrial tumor. J Biol Chem, 2000, 275 (27): 20540-20544
4. Uria J A, Lopez Otin C. Matrilysin-2, a new matrix metalloproteinase expressed in human tumors and showing the minimal domain organization required for secretion, latency, and activity. Cancer Res, 2000, 60 (17): 4745-4751
5. Marchenko G N, Ratnikov B I, Rozanov D V, et al. Characterization of matrix metalloproteinase-26, a novel metalloproteinase widely expressed in cancer cells of epithelial origin. Biochem J, 2001, 356 (3): 705-718
6. Chegini N, Rhoton V A, Williams R S. Expression of matrix metalloproteinase-26 and tissue inhibitor of matrix metalloproteinase-3 and -4 in endometrium throughout the normal menstrual cycle and alteration in users of levonorgestrel implants who experience irregular uterine bleeding. Fertil Steril, 2003, 80 (3): 564-570
7. Pilka R, Whatling C, Domanski H, et al. Epithelial expression of matrix metalloproteinase-26 is elevated at mid-cycle in the human endometrium. Mol Hum Reprod, 2003, 9 (5): 271-277
8. Li Q, Wang H, Zhao Y, et al. Identification and specific expression of matrix metalloproteinase-26 in rhesus monkey endometrium during early pregnancy. Mol Hum Reprod, 2002, 8(10): 934-940
9. Zhang J, Cao Y J, Zhao Y G, et al. Expression of matrix metalloproteinase-26 and tissue inhibitor of metalloproteinase-4 in human normal cytotrophoblast cells and a choriocarcinoma cell line, JEG-3. Mol Hum Reprod, 2002, 8 (7): 659-666
10. Rebecca L J, Lois A S, Zhao Y C, et al. Expression of activin receptors, follistatin and betaglycan by human endometrial stromal cells; consistent with a role for activins during decidualization. Mol Hum Reprod, 2002, 8 (4): 363-374
11. Caniggia I, Lye S J, Cross J C. Activin is a local regulator of human cytotrophoblast cell differentiation. Endocrinology, 1997, 138 (9): 3976-3986
12. Petraglia F, Vaughan J, Vale W. Inhibin and activin modulate the release of gonadotropin-releasing hormone, human chorionic gonadotropin and progesterone from cultured human placental cells. Proc Natl Acad Sci USA, 1989, 86 (13): 5114-5117
13. Qin L, Wang Y L, Bai S X, et al. Expression of integrins and extracellular matrix proteins at the maternal-fetal interface during tubal implantation. Reproduction, 2003, 126 (3): 383-391
14. Li R H, Zhuang L Z. Study on reproductive endocrinology of human placenta - culture of highly purified cytotrophoblast cell in serum-free hormone supplemented medium. Sci Chin B, 1991, 34 (8): 938-946
15. Woessner J F, Nagase H. Matrix Metalloproteinases and TIMPs. New York: Oxford University Press, 2000. 14-30
16. Zhao Y G, Xiao A Z, Newcomer R G, et al. Activation of pro-gelatinase B by endometase/matrilysin-2 promotes invasion of human prostate cancer cells. J Biol Chem, 2003, 278 (17): 15056-15064
17. Bai S X, Wang Y L, Qin L, et al. Temporal and spatial expression of MMP-2, -9 and -14 and the tissue inhibitor (TIMP-1,2,3) at the implantation site during tubal pregnancy of human. Reproduction, 2005, 129 (1): 103-113
18. Aplin J D, Haigh T, Jones C J, et al. Development of cytotrophoblast columns from explanted first-trimester human placental villi: role of fibronectin and integrin alpha5beta1. Biol Reprod, 1999, 60 (4): 828-838
19. Qu J. Inhibin and activin production in human placenta. Endocrine Rev, 1995, 16 (4): 485-507
20. Euan M W, Budi M, Katrina T, et al. First trimester levels of inhibins and activin A in normal and failing pregnancies. Clin Endocrinol, 2004, 60 (4): 484-490